Kiniksa Pharmaceuticals LtdNASDAQ:KNSA
- LAST PRICE22.5700
- TODAY'S CHANGE (%)-0.4400 (-1.9122%)
- Bid / Lots18.0000/ 1
- Ask / Lots24.8800/ 1
- Open / Previous Close22.8700 / 23.0100
- Day Range
- 52 Week Range
- Volume474,357
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | KNSA |
|---|---|---|
| 09:32 ET | 5830 | 22.92 |
| 09:34 ET | 2769 | 22.79 |
| 09:38 ET | 300 | 22.835 |
| 09:41 ET | 1700 | 23.045 |
| 09:43 ET | 100 | 23.2 |
| 09:45 ET | 1390 | 23.14 |
| 09:48 ET | 3000 | 23.06 |
| 09:50 ET | 264 | 23.08 |
| 09:52 ET | 300 | 23.08 |
| 09:56 ET | 2500 | 23.01 |
| 09:57 ET | 100 | 23.05 |
| 10:01 ET | 100 | 23.01 |
| 10:03 ET | 200 | 23 |
| 10:06 ET | 2000 | 23.0025 |
| 10:08 ET | 3193 | 23.07 |
| 10:10 ET | 500 | 23.1 |
| 10:12 ET | 200 | 23.09 |
| 10:15 ET | 4458 | 22.865 |
| 10:17 ET | 1900 | 23.015 |
| 10:19 ET | 400 | 23.06 |
| 10:21 ET | 200 | 23.1 |
| 10:24 ET | 200 | 23.06 |
| 10:26 ET | 340 | 23.11 |
| 10:28 ET | 100 | 23.095 |
| 10:30 ET | 2200 | 23.15 |
| 10:32 ET | 600 | 23.065 |
| 10:33 ET | 230 | 23.06 |
| 10:35 ET | 100 | 23.055 |
| 10:37 ET | 600 | 23.055 |
| 10:39 ET | 1500 | 23.03 |
| 10:42 ET | 300 | 23.02 |
| 10:46 ET | 400 | 23.02 |
| 10:48 ET | 872 | 22.99 |
| 10:51 ET | 500 | 22.98 |
| 10:53 ET | 1000 | 23.04 |
| 10:55 ET | 100 | 23.05 |
| 10:57 ET | 100 | 23.03 |
| 11:02 ET | 2000 | 22.93 |
| 11:04 ET | 5200 | 22.91 |
| 11:06 ET | 100 | 22.895 |
| 11:08 ET | 900 | 22.905 |
| 11:09 ET | 16904 | 22.87 |
| 11:11 ET | 300 | 22.89 |
| 11:13 ET | 1526 | 22.78 |
| 11:15 ET | 1364 | 22.77 |
| 11:18 ET | 1200 | 22.79 |
| 11:20 ET | 900 | 22.81 |
| 11:22 ET | 3723 | 22.88 |
| 11:24 ET | 5200 | 22.91 |
| 11:26 ET | 700 | 22.87 |
| 11:27 ET | 200 | 22.86 |
| 11:33 ET | 200 | 22.81 |
| 11:38 ET | 300 | 22.81 |
| 11:40 ET | 300 | 22.83 |
| 11:42 ET | 780 | 22.82 |
| 11:45 ET | 1750 | 22.77 |
| 11:47 ET | 700 | 22.6364 |
| 11:51 ET | 200 | 22.62 |
| 11:58 ET | 400 | 22.54 |
| 12:00 ET | 200 | 22.53 |
| 12:02 ET | 1500 | 22.62 |
| 12:05 ET | 138 | 22.625 |
| 12:09 ET | 1146 | 22.58 |
| 12:12 ET | 993 | 22.5544 |
| 12:16 ET | 248 | 22.58 |
| 12:18 ET | 486 | 22.54 |
| 12:20 ET | 200 | 22.545 |
| 12:23 ET | 2860 | 22.52 |
| 12:25 ET | 200 | 22.53 |
| 12:27 ET | 3100 | 22.54 |
| 12:30 ET | 100 | 22.53 |
| 12:36 ET | 100 | 22.53 |
| 12:39 ET | 1988 | 22.46 |
| 12:41 ET | 200 | 22.44 |
| 12:43 ET | 180 | 22.43 |
| 12:45 ET | 699 | 22.435 |
| 12:48 ET | 100 | 22.42 |
| 12:52 ET | 333 | 22.41 |
| 12:54 ET | 128 | 22.39 |
| 12:56 ET | 100 | 22.38 |
| 12:57 ET | 400 | 22.405 |
| 12:59 ET | 300 | 22.39 |
| 01:01 ET | 200 | 22.37 |
| 01:06 ET | 400 | 22.36 |
| 01:08 ET | 200 | 22.36 |
| 01:10 ET | 200 | 22.36 |
| 01:14 ET | 100 | 22.36 |
| 01:15 ET | 100 | 22.34 |
| 01:17 ET | 1500 | 22.44 |
| 01:21 ET | 1308 | 22.43 |
| 01:24 ET | 200 | 22.44 |
| 01:26 ET | 369 | 22.43 |
| 01:28 ET | 400 | 22.44 |
| 01:30 ET | 2034 | 22.58 |
| 01:32 ET | 1093 | 22.63 |
| 01:33 ET | 200 | 22.66 |
| 01:35 ET | 268 | 22.635 |
| 01:37 ET | 150 | 22.64 |
| 01:42 ET | 1803 | 22.67 |
| 01:44 ET | 200 | 22.67 |
| 01:46 ET | 500 | 22.66 |
| 01:48 ET | 557 | 22.634 |
| 01:50 ET | 4811 | 22.493 |
| 01:51 ET | 282 | 22.465 |
| 01:55 ET | 540 | 22.405 |
| 01:57 ET | 200 | 22.39 |
| 02:00 ET | 400 | 22.46 |
| 02:02 ET | 625 | 22.44 |
| 02:04 ET | 302 | 22.42 |
| 02:06 ET | 802 | 22.43 |
| 02:08 ET | 332 | 22.43 |
| 02:11 ET | 4300 | 22.58 |
| 02:13 ET | 837 | 22.61 |
| 02:18 ET | 1700 | 22.625 |
| 02:20 ET | 3046 | 22.55 |
| 02:22 ET | 136 | 22.57 |
| 02:24 ET | 300 | 22.53 |
| 02:27 ET | 100 | 22.54 |
| 02:31 ET | 700 | 22.57 |
| 02:33 ET | 532 | 22.54 |
| 02:36 ET | 100 | 22.55 |
| 02:38 ET | 1700 | 22.56 |
| 02:44 ET | 100 | 22.55 |
| 02:45 ET | 100 | 22.52 |
| 02:47 ET | 100 | 22.53 |
| 02:49 ET | 100 | 22.53 |
| 02:51 ET | 200 | 22.53 |
| 02:54 ET | 606 | 22.55 |
| 02:56 ET | 600 | 22.5427 |
| 02:58 ET | 600 | 22.54 |
| 03:00 ET | 100 | 22.54 |
| 03:02 ET | 347 | 22.5346 |
| 03:03 ET | 645 | 22.53 |
| 03:05 ET | 1500 | 22.52 |
| 03:07 ET | 1000 | 22.53 |
| 03:09 ET | 13993 | 22.61 |
| 03:12 ET | 421 | 22.655 |
| 03:14 ET | 905 | 22.59 |
| 03:16 ET | 950 | 22.57 |
| 03:20 ET | 525 | 22.54 |
| 03:21 ET | 200 | 22.54 |
| 03:23 ET | 700 | 22.55 |
| 03:25 ET | 183 | 22.54 |
| 03:27 ET | 300 | 22.54 |
| 03:30 ET | 200 | 22.53 |
| 03:32 ET | 110 | 22.56 |
| 03:34 ET | 100 | 22.55 |
| 03:36 ET | 1000 | 22.535 |
| 03:38 ET | 1100 | 22.555 |
| 03:41 ET | 1592 | 22.52 |
| 03:43 ET | 400 | 22.53 |
| 03:45 ET | 500 | 22.54 |
| 03:48 ET | 11836 | 22.53 |
| 03:50 ET | 3626 | 22.52 |
| 03:52 ET | 9333 | 22.52 |
| 03:54 ET | 7402 | 22.54 |
| 03:56 ET | 2482 | 22.59 |
| 03:57 ET | 3404 | 22.64 |
| 03:59 ET | 73500 | 22.57 |
Yesterday
DJ Kiniksa Pharmaceuticals Is Maintained at Outperform by Evercore ISI Group, from 11:07AM ET on Wednesday Oct 30, 2024 by Dow Jones
11:07AM ET on Wednesday Oct 30, 2024 by Dow Jones
Oct 29, 2024
DJ Kiniksa Pharmaceuticals Down Over 12%, on Pace for Largest Percent Decrease Since August 2021 -- Data Talk, from 11:09AM ET on Tuesday Oct 29, 2024 by Dow Jones
11:09AM ET on Tuesday Oct 29, 2024 by Dow JonesKiniksa Pharmaceuticals Reports Third Quarter 2024 Financial Results and Recent Portfolio Execution, from 7:30AM ET on Tuesday Oct 29, 2024 by Dow Jones
7:30AM ET on Tuesday Oct 29, 2024 by Dow Jones*DJ Kiniksa Pharmaceuticals 3Q Loss/Shr 18c >KNSA, from 7:30AM ET on Tuesday Oct 29, 2024 by Dow Jones
7:30AM ET on Tuesday Oct 29, 2024 by Dow Jones
Oct 28, 2024
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Kiniksa Pharmaceuticals Ltd | 1.6B | -142.5x | --- |
Dynavax Technologies Corp | 1.6B | 117.2x | --- |
Maravai LifeSciences Holdings Inc | 1.9B | -7.4x | --- |
BioCryst Pharmaceuticals Inc | 1.7B | -11.0x | --- |
CareDx Inc | 1.2B | -7.4x | --- |
MannKind Corp | 1.9B | 197.0x | --- |
Company Information
Kiniksa Pharmaceuticals, Ltd. is a biopharmaceutical company. The Company is focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. Its portfolio of immune-modulating assets, ARCALYST (rilonacept), KPL-404 and mavrilimumab, are based on strong biologic rationale or validated mechanisms, target a spectrum of underserved cardiovascular and autoimmune conditions, and offer the potential for differentiation. The Company’s ARCALYST is interleukin-1alpha (IL-1α), and interleukin-1beta (IL-1β), cytokine trap for the treatment of recurrent pericarditis and reduction in risk of recurrence in adults and children. Its KPL-404 is an investigational monoclonal antibody inhibitor of CD40-CD154 interaction. The Company’s Mavrilimumab is an investigational monoclonal antibody inhibitor targeting granulocyte-macrophage colony stimulating factor receptor alpha (GM-CSFRα).
Contact Information
- Headquarters
- Clarendon House, 2 Church StreetHAMILTON, Bermuda HM11
- Phone
- ---
- Fax
- ---
Executives
- Chairman of the Board, Chief Executive Officer
- Sanjiv Patel
- Chief Financial Officer, Senior Vice President
- Mark Ragosa
- Chief Operating Officer, Senior Vice President
- Eben Tessari
- Senior Vice President, Chief Commercial Officer
- Ross Moat
- Senior Vice President, Chief Medical Officer
- John Paolini
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.6B |
|---|---|
Revenue (TTM) | $384.1M |
Shares Outstanding | 71.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.33 |
EPS | $-0.16 |
Book Value | $6.23 |
P/E Ratio | -142.5x |
Price/Sales (TTM) | 4.3 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -6.83% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
